BENF — Beneficient Income Statement
0.000.00%
- $2.28m
- $392.49m
- -$98.70m
Annual income statement for Beneficient, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 15 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 140 | -11.3 | -105 | -98.7 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 188 | 194 | 148 | 2,559 |
Operating Profit | -47.4 | -205 | -253 | -2,657 |
Net Income Before Taxes | -47.4 | -205 | -253 | -2,657 |
Provision for Income Taxes | ||||
Net Income After Taxes | -50.9 | -206 | -252 | -2,658 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | -58 | -139 | -131 | -2,096 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -58 | -139 | -131 | -2,096 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -23.3 | -47.1 | -52.6 | -164 |
Dividends per Share |